Cocrystal Discovery
Biotechnology company developing antiviral therapeutics for human diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€27—41m (Dealroom.co estimates Sep 2011.)
Bothell Washington (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $7.7m | Early VC | |
$7.5m | Early VC | ||
N/A | Acquisition | ||
Total Funding | €13.8m |
Related Content
Recent News about Cocrystal Discovery
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.